Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis

医学 内科学 临床终点 二十碳五烯酸 心脏病学 随机对照试验 脂肪酸 多不饱和脂肪酸 化学 有机化学
作者
Mitsuhiro Yokoyama,Hideki Origasa,Masunori Matsuzaki,Yūji Matsuzawa,Yasushi Saitō,Yuichi Ishikawa,Shinichi Oikawa,Junichi Sasaki,Hitoshi Hishida,Hiroshige Itakura,Toru Kita,Akira Kitabatake,Noriaki Nakaya,Toshiie Sakata,Kazuyuki Shimada,Kunio Shirato
出处
期刊:The Lancet [Elsevier BV]
卷期号:369 (9567): 1090-1098 被引量:2413
标识
DOI:10.1016/s0140-6736(07)60527-3
摘要

Background Epidemiological and clinical evidence suggests that an increased intake of long-chain n-3 fatty acids protects against mortality from coronary artery disease. We aimed to test the hypothesis that long-term use of eicosapentaenoic acid (EPA) is effective for prevention of major coronary events in hypercholesterolaemic patients in Japan who consume a large amount of fish. Methods 18 645 patients with a total cholesterol of 6·5 mmol/L or greater were recruited from local physicians throughout Japan between 1996 and 1999. Patients were randomly assigned to receive either 1800 mg of EPA daily with statin (EPA group; n=9326) or statin only (controls; n=9319) with a 5-year follow-up. The primary endpoint was any major coronary event, including sudden cardiac death, fatal and non-fatal myocardial infarction, and other non-fatal events including unstable angina pectoris, angioplasty, stenting, or coronary artery bypass grafting. Analysis was by intention-to-treat. The study was registered at ClinicalTrials.gov, number NCT00231738. Findings At mean follow-up of 4·6 years, we detected the primary endpoint in 262 (2·8%) patients in the EPA group and 324 (3·5%) in controls—a 19% relative reduction in major coronary events (p=0·011). Post-treatment LDL cholesterol concentrations decreased 25%, from 4·7 mmol/L in both groups. Serum LDL cholesterol was not a significant factor in a reduction of risk for major coronary events. Unstable angina and non-fatal coronary events were also significantly reduced in the EPA group. Sudden cardiac death and coronary death did not differ between groups. In patients with a history of coronary artery disease who were given EPA treatment, major coronary events were reduced by 19% (secondary prevention subgroup: 158 [8·7%] in the EPA group vs 197 [10·7%] in the control group; p=0·048). In patients with no history of coronary artery disease, EPA treatment reduced major coronary events by 18%, but this finding was not significant (104 [1·4%] in the EPA group vs 127 [1·7%] in the control group; p=0·132). Interpretation EPA is a promising treatment for prevention of major coronary events, and especially non-fatal coronary events, in Japanese hypercholesterolaemic patients.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
香蕉觅云应助粉条采纳,获得10
3秒前
英姑应助Nicole采纳,获得10
4秒前
朴实子骞完成签到 ,获得积分10
5秒前
chenxin完成签到,获得积分10
6秒前
Iiiilr完成签到 ,获得积分10
6秒前
生动刺猬发布了新的文献求助10
6秒前
852应助小萝卜采纳,获得10
7秒前
夕阳与茶完成签到,获得积分10
7秒前
佳佳应助CyS采纳,获得10
7秒前
8秒前
乱武完成签到,获得积分10
8秒前
Aloha完成签到,获得积分10
9秒前
10秒前
11应助夕阳与茶采纳,获得10
11秒前
HJJHJH发布了新的文献求助50
12秒前
13秒前
eeeating完成签到,获得积分10
14秒前
田様应助notsoeasy采纳,获得10
15秒前
刘旋发布了新的文献求助10
15秒前
和谐绍辉完成签到,获得积分20
15秒前
科研通AI2S应助CyS采纳,获得10
15秒前
CC发布了新的文献求助10
15秒前
16秒前
张雷应助1x3采纳,获得20
16秒前
18秒前
帅气访天完成签到,获得积分10
18秒前
小萝卜发布了新的文献求助10
20秒前
粉条发布了新的文献求助10
20秒前
小鱼完成签到,获得积分10
20秒前
21秒前
跳跃的邪欢完成签到,获得积分10
22秒前
小宋完成签到,获得积分10
23秒前
Iiirds完成签到 ,获得积分10
23秒前
20250702发布了新的文献求助10
23秒前
大模型应助tingting采纳,获得10
25秒前
和谐绍辉发布了新的文献求助10
25秒前
26秒前
26秒前
科研通AI5应助ttttt采纳,获得10
27秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3976210
求助须知:如何正确求助?哪些是违规求助? 3520366
关于积分的说明 11203088
捐赠科研通 3256965
什么是DOI,文献DOI怎么找? 1798570
邀请新用户注册赠送积分活动 877738
科研通“疑难数据库(出版商)”最低求助积分说明 806516